Sudarshan Pharma Industries Ltd
SUDARSHANSudarshan Pharma Industries Ltd
SUDARSHAN
Pharmaceuticals
SmallcapWith a market cap of ₹188 cr, stock is ranked 2,111
High RiskStock is 4.81x as volatile as Nifty
83.005.88% (+4.61)
83.005.88% (+4.61)
Price Chart
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 1.87 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| -266.47 | 1.15 | 0.03% |
Forecast & Ratings
Detailed Forecast—
Forecast data is currently unavailable for this stockPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Hmm, looks like data is unavailable here. Please come back after some timePeers
Compare with peersSun Pharmaceutical Industries Ltd
PE Ratio
34.71
1Y Return
17.66%
Buy Reco %
94.12
Cipla Ltd
PE Ratio
34.93
1Y Return
7.18%
Buy Reco %
65.71
Dr Reddy's Laboratories Ltd
PE Ratio
21.38
1Y Return
28.50%
Buy Reco %
48.65
Mankind Pharma Ltd
PE Ratio
59.30
1Y Return
34.57%
Buy Reco %
45.45
Torrent Pharmaceuticals Ltd
PE Ratio
57.80
1Y Return
31.04%
Buy Reco %
67.86
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Annual Normal View
Income Statement
Annual Normal View
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 37.94 | 55.52 | 89.77 | 140.02 | 148.00 | 193.73 | 357.55 | 462.45 | — | |||||||||
Raw Materials | 35.51 | 54.53 | 86.47 | 132.85 | 144.83 | 184.18 | 358.01 | 457.57 | — | |||||||||
| Power & Fuel Cost | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Employee Cost | 0.26 | 0.78 | 2.26 | 2.32 | 1.50 | 1.38 | 1.68 | 2.08 | ||||||||||
| Selling & Administrative Expenses | 1.16 | 1.24 | 1.89 | 2.04 | 3.10 | 3.41 | 3.49 | 5.04 | ||||||||||
| Operating & Other expenses | 0.62 | -1.79 | -3.13 | -2.41 | -6.22 | -2.79 | -17.01 | -18.04 | ||||||||||
EBITDA | 0.39 | 0.76 | 2.28 | 5.22 | 4.79 | 7.55 | 11.38 | 15.80 | — | |||||||||
| Depreciation/Amortization | 0.02 | 0.08 | 0.06 | 0.15 | 0.35 | 0.74 | 0.87 | 0.91 | — | |||||||||
| PBIT | 0.37 | 0.68 | 2.22 | 5.07 | 4.44 | 6.81 | 10.51 | 14.89 | — | |||||||||
| Interest & Other Items | 0.23 | 0.43 | 1.23 | 1.81 | 2.72 | 3.23 | 3.38 | 5.40 | — | |||||||||
| PBT | 0.14 | 0.25 | 0.99 | 3.26 | 1.72 | 3.58 | 7.13 | 9.49 | — | |||||||||
| Taxes & Other Items | 0.05 | 0.10 | 0.24 | 0.92 | 0.44 | 0.91 | 1.88 | 2.46 | — | |||||||||
| Net Income | 0.09 | 0.15 | 0.75 | 2.34 | 1.28 | 2.67 | 5.25 | 7.03 | — | |||||||||
| EPS | 52.94 | 0.81 | 1.28 | 2.66 | 1.34 | 2.80 | 5.44 | 4.16 | — | |||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | |||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Company Updates
FY 2023
Annual report
PDFPeers & Comparison
Comparing 3 stocks from
Pharmaceuticals
Compare valuation on Screener
Pharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Sudarshan Pharma Industries Ltd | 26.84 | 1.87 | — |
| Sun Pharmaceutical Industries Ltd | 34.71 | 4.96 | 0.94% |
| Cipla Ltd | 34.93 | 4.13 | 0.70% |
| Dr Reddy's Laboratories Ltd | 21.38 | 4.14 | 0.69% |
Price Comparison
Compare SUDARSHAN with any stock or ETFCompare SUDARSHAN with any stock or ETF
SUDARSHAN
Shareholdings
Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Institutional Holdings Trend
No institutional holdings trend are available
Shareholding Pattern
Mar 2023
Sep 2023
Shareholding History
Foreign Institutions
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
SUDARSHAN has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateAug 25, 2023
Final
Final | Div/Share: ₹0.30
Dividend/Share
₹0.30
Ex DateEx Date
Aug 25, 2023
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 38.8%, vs industry avg of 8.45%
Increasing Market Share
Over the last 5 years, market share increased from 0.04% to 0.14%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 56.45%, vs industry avg of 9.82%